Category HORIZON 2020 PROJECTS

Masters of Science (MSc) degree in ATMPs has opened to enrolment at the University of Manchester

Under the guidance of the iMATCH team,  a new Masters of Science (MSc) degree in Advanced Therapy Medicinal Products (ATMPs) has opened to enrolment at the University of Manchester. This course is believed to be a world first focussing on this rapidly evolving area of medicine which is increasingly being used to treat a broad

Read More


Global Innovation Index 2019: the future for medical innovation. RESTORE community topics at the tops

The World Intellectual Property Organization, WIPO, named Switzerland as the world’s most innovative country on Wednesday, during the launch of its latest Global Innovation Index, (GII) in the Indian capital New Delhi. Following Switzerland in the rankings are Sweden, the United States, the Netherlands and the United Kingdom. India has risen most in the rankings since

Read More


RESTORE Large Scale Research Initiative presents 1st Advanced Therapies Science Meeting

Shifting from treating symptoms to curing chronic diseases by making the transformative promise of Advanced Therapies a reality for the benefit of patients, that is the vision of the international project RESTORE Health by Advanced Therapies. For genetic diseases, immune diseases, cancer and tissue injury potential cures through Advanced Therapies exist – they are reality,

Read More


Europe urged to adapt faster to gene therapy challenges

Resistance to high prices, even with novel payment models Europe’s leading nations should commit to a rapid overhaul of health technology assessment (HTA) and bold initiatives such as new pan-European real world evidence (RWE) frameworks, in order to nurture the nascent cell and gene therapy revolution in the region. That is the conclusion of a

Read More


RESTORE Community produced a new video for ATMP’s diffusion

Large Scale Research Initiative RESTORE The visionary unifying goal of Large Scale Research Initiative RESTORE is to make the transforming promise associated with Advanced Therapies a reality for the benefit of patients and society. RESTORE sees itself as a “place” where medicine, basic research, technology development and engineering meet, communicate and work together. Through this

Read More


EU awards 742 million euro to 1,062 Israeli science projects

Special recognition award given to 423 Israeli companies and researchers that won the Horizon 2020 grant in 2018. The EU Delegation to Israel, together with the Israel-Europe Research and Innovation Directorate (ISERD) and the Israel Innovation Authority, celebrated scientific cooperation under the Horizon 2020 program with an awards ceremony on June 4th at the Peres

Read More


Advanced Therapies Clinical Adoption by Cell and Gene Therapy Catapult

The UK ATTC Network is a world-first system of Advanced Therapy Treatment Centres (ATTCs), operating within the NHS framework and coordinated by CGT Catapult, that is addressing the unique and complex challenges of bringing pioneering advanced therapies to patients. The project has been funded by the Industrial Strategy Challenge Fund, part of the government’s modern Industrial Strategy,

Read More


Advanced therapies and carT cells in the next IMI2 calls

Future topics To give potential applicants as much time as possible to form consortia and prepare their proposals, IMI regularly publishes information on possible future topics well in advance of the official Call launch. To ensure you get the latest information on forthcoming Calls, sign up to our newsletter, follow us on Twitter, or join our LinkedIn group.

Read More


How Europe will spend €100 billion in its next research programme

Source Nature One day before the last parliament dissolved, on 17 April, negotiators signed off on the general outlines of the union’s next giant research programme, known as Horizon Europe, which runs from 2021 to 2027. The EU’s much sought after multi-year research programmes support academic and commercial research across its 28 member states and

Read More


GE Healthcare announces commercial launch of Chronicle™ automation software for cell therapy

GMP compliant software specifically designed for cell therapy manufacturing from process development through commercialization Digital optimization for increased productivity and improved process control  GE Healthcare builds on its digital capabilities with the Chronicle web application, the next generation development of my Cryochain™ software now supporting the complete cell therapy workflow. Chronicle automation software is a

Read More